ARCHIVES

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Rushing To Complete Development Of Program Grants System By June 30

May 17, 1974

Wyden, Schroeder Bill Would Require NIH To Test RU 486

October 23, 1992

Seattle Panel Meeting Generate More Support For Increased Outreach Funding, Consortium Approached

November 2, 1984

NCI Sets Initial R01 Payline At 18th Percentile Under CR.

November 24, 2000

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

November 1, 1985

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

October 17, 1997